Trial intelligence / Profile preview

ACE inhibitor–induced angioedema treatment study

2012-001670-28Phase 3Terminated

Sponsor
Technical University of Munich Faculty of Medicine
Start
Aug 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 3 trial of c1-esterase inhibitor, prednisolone and clemastine in angioedema, sponsored by Technical University of Munich Faculty of Medicine. Started Aug 2012; status: terminated.

02

Drugs

c1-esterase inhibitorprednisoloneclemastine
03

Conditions

angioedema

Beyond the preview

Go deeper on 2012-001670-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001670-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call